
VRDN
USDViridian Therapeutics Inc. Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$22.720
High
$23.050
Low
$22.140
Volume
4.98M
Company Fundamentals
Market Cap
2.1B
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
1.03M
Exchange
NCM
Currency
USD
52-Week Range
Related News
BTIG Reiterates Buy on Viridian Therapeutics, Maintains $61 Price Target
BTIG analyst Julian Harrison reiterates Viridian Therapeutics with a Buy and maintains $61 price target.
Viridian Therapeutics Announces Successful October Submission of Biologics License Application (BLA) to U.S. FDA for Veligrotug in Thyroid Eye Disease
- BLA for veligrotug successfully submitted to the U.S. Food and Drug Administration (FDA) in late October following recent consultation with the agency - - Veligrotug's Breakthrough Therapy Designation supports
Related Stocks
SSSSL
SuRo Capital Corp. 6.00% Notes due 2026
NREF
NexPoint Real Estate Finance Inc.
INO
Inovio Pharmaceuticals Inc.
VPV
Invesco Pennsylvania Value Municipal Income Trust (DE)
SIRI
Sirius XM Holdings Inc.
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.